Biggest Volume Stocks Losers are SOMX, ALTH, KBX

To get free alerts on Top Stocks, subscribe to Stock Markets Alerts by visiting:  http://www.pennystockpickreport.com/

Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) is down 57.52% to $1.50 on 20.09 million shares after the company announced that the Company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor (doxepin) for the treatment of insomnia. Based on its review, the FDA has determined that the NDA cannot be approved in its present form. Somaxon previously received a Complete Response Letter for the NDA in February 2009, and it resubmitted the NDA in June 2009.

Allos Therapeutics, Inc. (NASDAQ:ALTH) went down 14.95% to $5.63 on 5.22 million shares. The stock is up over 22% from its 52-week low and has a market capitalization of $688.08 million. In the last six months the stock went down over 22%. Allos Therapeutics, Inc. is a biopharmaceutical company that is focused on developing and commercializing small molecule drugs for the treatment of cancer. The Company’s lead product candidate, pralatrexate (PDX) an antifolate, is in Phase II trial in patients with relapsed or refractory peripheral T-cell lymphoma.

Kimber Resources, Inc. (AMEX:KBX) declines 14.01% to $1.22. The stock is up over 205% from its 52-week low and has a market capitalization of $88.17 million. In the last six months the stock went up over 77%. Kimber Resources Inc. is a Canada-based exploration-stage company, engaged in the acquisition and exploration of mineral right interests in Mexico. The Company focuses on gold-silver exploration in Mexico.